GPE vs BDNF
Head-to-head comparison of GPE (Glycyl-L-prolyl-L-glutamic acid) and BDNF (Brain-Derived Neurotrophic Factor (mature BDNF)) — benefits, dosing, side effects, research data, and where to buy.
| Property | GPE | BDNF |
|---|---|---|
| Category | Cognitive Enhancement | Cognitive Enhancement |
| Full Name | Glycyl-L-prolyl-L-glutamic acid | Brain-Derived Neurotrophic Factor (mature BDNF) |
| Molecular Weight | 301.30 Da | 13,700 Da |
| Half-Life | minutes | minutes to hours |
| Amino Acids | 3 | 119 aa |
| Typical Dose | 0.1-10 mg/kg preclinical | research-only microgram range |
| Route | Intranasal/Intracerebroventricular | Intranasal |
| Purity | ≥98% | ≥98% |
| Studies Count | 25 | 8000 |
| Research Status | Pre-clinical | Pre-clinical |
GPE Benefits
- ✓memory consolidation
- ✓neuroprotection
- ✓synaptic plasticity
- ✓learning support
BDNF Benefits
- ✓neurogenesis
- ✓synaptogenesis
- ✓LTP support
- ✓neuronal survival
GPE Dosing
intranasal or ICV research doses|0.1-10 mg/kg preclinical range|repeat daily or intermittent protocols
BDNF Dosing
0.1-1 µg local or intranasal research delivery|viral or protein infusion models|acute or repeated plasticity protocols
GPE Side Effects
- ⚠limited human safety data
- ⚠short half-life
- ⚠local irritation with nasal delivery
BDNF Side Effects
- ⚠off-target neuroexcitation
- ⚠headache-like effects
- ⚠unknown systemic protein effects
Research Overview
GPE
Preclinical studies suggest GPE can reduce neuronal damage and support plasticity-related pathways in the brain. Research interest centers on hippocampal function, which links it to learning and memory paradigms.
BDNF
BDNF is repeatedly associated with learning, long-term potentiation, and recovery from neurologic injury in preclinical literature. Direct protein delivery is difficult, so most studies focus on pathways that raise endogenous BDNF or on localized experimental administration.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.